Hospital of Lithuanian university of health sciences
Kaunas, LT 44307, Lithuania
NCT Number: NCT01332734
During infections (sepsis) bloodflow in small vessels (microcirculation) becomes disturbed. Restoration of bloodpressure and cardiac performance may not be sufficient to correct these alterations. Magnesium is a potent vasodilator which may be used to open up the small vessels, in order to reduce organ failure.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Kaunas, LT 44307, Lithuania
In a single-center open label study we evaluated the effects of magnesium sulphate (MgS) infusion on the sublingual microcirculation perfusion in fluid resuscitated patients with severe sepsis and septic shock within the first 48 hours after ICU admission. Directly prior to and after 1 hour of magnesium sulphate (MgS) infusion (2 gram) systemic hemodynamic variables, sublingual SDF images and standard laboratory tests, were obtained.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
2 gram in 1 hour
Time frame: 1 hour
Directly prior to and after 1 hour of magnesium sulphate (MgS) infusion (2 gram) systemic hemodynamic variables, sublingual SDF images and standard laboratory tests, were obtained.
Frisius Medisch Centrum
Other
Microcirculatory Changes During Open Label Magnesium Sulphate Infusion in Severe Sepsis and Septic Shock
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02361528
Infections, Inflammation
Amiens, France
View Trial DetailsNCT00793442
Infections, Inflammation
Birmingham, Alabama, United States
View Trial DetailsNCT02041663
Bacterial Infections, Bacterial Infections and Mycoses
Paris, France
View Trial DetailsNCT03077672
Disease Attributes, Emergencies
Brooklyn, New York, United States
View Trial Details